Press "Enter" to skip to content

BRIEF-Takeda & Novavax Announce Collaboration For…

Aug 7 – Takeda Pharmaceutical Co Ltd:

* NOVAVAX AND TAKEDA ANNOUNCE COLLABORATION FOR NOVAVAX’ COVID-19 VACCINE CANDIDATE IN JAPAN

* SEES CAPACITY TO MANUFACTURE OVER 250 MILLION DOSES OF COVID-19 VACCINE PER YEAR

* NOVAVAX & TAKEDA TO PARTNER FOR DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF NVX-COV2373 IN JAPAN

* NOVAVAX WILL LICENSE & TRANSFER MANUFACTURING TECHNOLOGIES TO ENABLE TAKEDA TO MANUFACTURE VACCINE ANTIGEN

* TO RECEIVE FUNDING FROM JAPAN’S MINISTRY OF HEALTH, LABOUR AND WELFARE TO SUPPORT MANUFACTURING Source text https://bit.ly/2Ca25GQ Further company coverage:

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *